2 FTSE 100 dividend stocks I’d buy today

With such a large number of companies cancelling or cutting dividends, income has been hard to come by. These dividend stocks should help fill the hole.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s been a pretty dismal year for income investors. A total of 445 companies listed on the London Stock Exchange have either cancelled, cut or suspended dividend payments. This has included previous big dividend-payers such as BT Group and Royal Dutch Shell. Nonetheless, some FTSE 100 companies have remained committed to payments, and these two dividend stocks are my top picks.

A pharmaceuticals giant

GlaxoSmithKline (LSE: GSK) is one of the leading healthcare companies in the world. The group operates in three different business segments, including pharmaceuticals, vaccines and consumer healthcare. And while this is seen as a fairly defensive sector, especially during a pandemic, the giant group hasn’t been immune to the impacts of coronavirus. For example, turnover in the vaccines sector fell by 29% in the second quarter as regular vaccination programmes were delayed. And adjusted operating profits were 19% lower than the previous year. This has seen its share price fall by 20% this year, leaving the stock looking very cheap indeed.

But it’s the firm’s status as a dividend stock that grabs my interest. While there has been limited dividend growth over the years, the company has consistently made dividend payments of 80p a year. At its currently depressed price, this equates to a very strong yield of 5.6%. With dividend cover of around 1.6, the payout is also well-covered by earnings, and I can’t see a cut coming any time soon. Consequently, I’d buy Glaxo shares at their current valuation.

A dividend stock yielding over 8%

Often a very high dividend yield can indicate limited growth in a company. A dividend cut may also be very likely at some point in the near future. Even so, in the case of Legal & General (LSE: LGEN), I think neither of these apply.

For example, the firm has seen significant growth in the past few years, with 2019 earnings rising 12% from the year before. The first-half trading update was also positive, and operating profits totalled £946m. This was only a 6% decrease compared to the same period in 2019, showing a strong performance in a difficult economic environment. I believe that the insurer should be able to continue growing profits over the next few years, thanks to its status as the UK’s leader in bulk annuities, life insurance and other retirement products. An ageing population should help to drive this growth.

Strong profits also allowed the group to announce an interim dividend of 4.93p. This corresponds to a total year payout of 17.57p, or a very high yield of 8.6%. The fact that the dividend was higher than the previous year further demonstrates LGEN’s standing as an excellent dividend stock. I reckon investors can expect further increases in the forthcoming years, and as such, I’d happily buy this stock today.

Stuart Blair owns shares in Legal & General and Royal Dutch Shell. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Rolls-Royce's Pearl 10X engine series
Investing Articles

Can the Rolls-Royce share price hit £16 in 2026? Here’s what the experts think

The Rolls-Royce share price has been unstoppable. Can AI data centres and higher defence spending keep the momentum going in…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

Up 150% in 5 years! What’s going on with the Lloyds share price?

The Lloyds share price has had a strong five years. Our writer sees reasons to think it could go even…

Read more »

Investing Articles

Where will Rolls-Royce shares go in 2026? Here’s what the experts say!

Rolls-Royce shares delivered a tremendous return for investors in 2025. Analysts expect next year to be positive, but slower.

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Up 40% this year, can the Vodafone share price keep going?

Vodafone shareholders have been rewarded this year with a dividend increase on top of share price growth. Our writer weighs…

Read more »

Buffett at the BRK AGM
Investing Articles

Here’s why I like Tesco shares, but won’t be buying any!

Drawing inspiration from famed investor Warren Buffett's approach, our writer explains why Tesco shares aren't on his shopping list.

Read more »

Investing For Beginners

If the HSBC share price can clear these hurdles, it could fly in 2026

After a fantastic year, Jon Smith points out some of the potential road bumps for the HSBC share price, including…

Read more »

Investing Articles

I’m thrilled I bought Rolls-Royce shares in 2023. Will I buy more in 2026?

Rolls-Royce has become a superior company, with rising profits, buybacks, and shares now paying a dividend. So is the FTSE…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

With Warren Buffett about to step down, what can investors learn?

Legendary investor Warren Buffett is about to hand over the reins of Berkshire Hathaway after decades in charge. How might…

Read more »